Sleep FAQs

Epithalon stimulates endogenous melatonin production (30-40% increases) rather than providing external melatonin, leading to more physiologically appr...

CJC-1295 reduces sleep fragmentation by optimizing growth hormone pulsatility, which promotes more consolidated sleep cycles and fewer nocturnal awake...

Growth hormone peptides like CJC-1295 and Ipamorelin typically increase REM sleep duration by 15-30% as GH levels normalize, with corresponding improv...

Clinical data suggests 65-75% of individuals with chronic sleep disturbances experience significant improvements with DSIP, particularly those with st...

Initial sleep improvements with Epithalon typically appear within 10-14 days as pineal melatonin synthesis increases, though full circadian normalizat...

Ipamorelin provides similar sleep quality enhancements to CJC-1295 through growth hormone secretion, with studies showing 15-25% increases in deep sle...

DSIP shows 55-65% effectiveness in shift workers struggling with non-traditional sleep schedules, primarily by reducing stress hormone interference wi...

DSIP (Delta Sleep-Inducing Peptide) has shown promise in clinical studies for enhancing slow-wave sleep duration by 15-25% in subjects with sleep dist...

Epithalon demonstrates measurable effects on circadian rhythm normalization by stimulating pineal gland melatonin production, with studies showing 30-...

CJC-1295 enhances sleep quality indirectly through growth hormone optimization, with users reporting 20-35% improvements in subjective sleep scores an...